208 related articles for article (PubMed ID: 20426472)
1. Colloid formation by drugs in simulated intestinal fluid.
Doak AK; Wille H; Prusiner SB; Shoichet BK
J Med Chem; 2010 May; 53(10):4259-65. PubMed ID: 20426472
[TBL] [Abstract][Full Text] [Related]
2. Colloidal aggregation affects the efficacy of anticancer drugs in cell culture.
Owen SC; Doak AK; Wassam P; Shoichet MS; Shoichet BK
ACS Chem Biol; 2012 Aug; 7(8):1429-35. PubMed ID: 22625864
[TBL] [Abstract][Full Text] [Related]
3. Is the full potential of the biopharmaceutics classification system reached?
Bergström CA; Andersson SB; Fagerberg JH; Ragnarsson G; Lindahl A
Eur J Pharm Sci; 2014 Jun; 57():224-31. PubMed ID: 24075971
[TBL] [Abstract][Full Text] [Related]
4. Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Seidler J; McGovern SL; Doman TN; Shoichet BK
J Med Chem; 2003 Oct; 46(21):4477-86. PubMed ID: 14521410
[TBL] [Abstract][Full Text] [Related]
5. Human intestinal fluid layer separation: The effect on colloidal structures & solubility of lipophilic compounds.
Riethorst D; Mitra A; Kesisoglou F; Xu W; Tack J; Brouwers J; Augustijns P
Eur J Pharm Biopharm; 2018 Aug; 129():104-110. PubMed ID: 29802985
[TBL] [Abstract][Full Text] [Related]
6. Bile Salt Micelles and Phospholipid Vesicles Present in Simulated and Human Intestinal Fluids: Structural Analysis by Flow Field-Flow Fractionation/Multiangle Laser Light Scattering.
Elvang PA; Hinna AH; Brouwers J; Hens B; Augustijns P; Brandl M
J Pharm Sci; 2016 Sep; 105(9):2832-2839. PubMed ID: 27103012
[TBL] [Abstract][Full Text] [Related]
7. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
8. Biopharmaceutics classification by high throughput solubility assay and PAMPA.
Obata K; Sugano K; Machida M; Aso Y
Drug Dev Ind Pharm; 2004 Feb; 30(2):181-5. PubMed ID: 15089052
[TBL] [Abstract][Full Text] [Related]
9. Dissolution properties of co-amorphous drug-amino acid formulations in buffer and biorelevant media.
Heikkinen AT; DeClerck L; Löbmann K; Grohganz H; Rades T; Laitinen R
Pharmazie; 2015 Jul; 70(7):452-7. PubMed ID: 26373205
[TBL] [Abstract][Full Text] [Related]
10. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
11. Aqueous solubility and true solutions.
Loftsson T
Pharmazie; 2010 Jun; 65(6):404-7. PubMed ID: 20614686
[TBL] [Abstract][Full Text] [Related]
12. Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations".
Buckley ST; Frank KJ; Fricker G; Brandl M
Eur J Pharm Sci; 2013 Sep; 50(1):8-16. PubMed ID: 23583787
[TBL] [Abstract][Full Text] [Related]
13. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test.
Takano R; Sugano K; Higashida A; Hayashi Y; Machida M; Aso Y; Yamashita S
Pharm Res; 2006 Jun; 23(6):1144-56. PubMed ID: 16715363
[TBL] [Abstract][Full Text] [Related]
14. Intestinal solubility and absorption of poorly water soluble compounds: predictions, challenges and solutions.
Fagerberg JH; Bergström CA
Ther Deliv; 2015; 6(8):935-59. PubMed ID: 26316058
[TBL] [Abstract][Full Text] [Related]
15. Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates.
Brummitt RK; Nesta DP; Chang L; Chase SF; Laue TM; Roberts CJ
J Pharm Sci; 2011 Jun; 100(6):2087-103. PubMed ID: 21213308
[TBL] [Abstract][Full Text] [Related]
16. A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption.
Augustijns P; Wuyts B; Hens B; Annaert P; Butler J; Brouwers J
Eur J Pharm Sci; 2014 Jun; 57():322-32. PubMed ID: 23994640
[TBL] [Abstract][Full Text] [Related]
17. Absorption sites of orally administered drugs in the small intestine.
Murakami T
Expert Opin Drug Discov; 2017 Dec; 12(12):1219-1232. PubMed ID: 28920464
[TBL] [Abstract][Full Text] [Related]
18. Co-existing colloidal phases in artificial intestinal fluids assessed by AF4/MALLS and DLS: A systematic study into cholate & (lyso-) phospholipid blends, incorporating celecoxib as a model drug.
Elvang PA; Jacobsen AC; Bauer-Brandl A; Stein PC; Brandl M
Eur J Pharm Sci; 2018 Jul; 120():61-72. PubMed ID: 29704643
[TBL] [Abstract][Full Text] [Related]
19. Molecular Dynamics Simulations of Self-Assembling Colloids in Fed-State Human Intestinal Fluids and Their Solubilization of Lipophilic Drugs.
Parrow A; Larsson P; Augustijns P; Bergström CAS
Mol Pharm; 2023 Jan; 20(1):451-460. PubMed ID: 36350845
[TBL] [Abstract][Full Text] [Related]
20. Solubility advantage of amorphous pharmaceuticals, part 3: Is maximum solubility advantage experimentally attainable and sustainable?
Murdande SB; Pikal MJ; Shanker RM; Bogner RH
J Pharm Sci; 2011 Oct; 100(10):4349-56. PubMed ID: 21630280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
